reproterol
Sign in to saveReproterol is a short-acting β2 adrenoreceptor agonist used in the treatment of asthma.
In the Vinony graph
Within Vinony's link graph, reproterol is referenced by 629 other articles, and connects out to propranolol, atenolol and adrenergic receptor.
It is catalogued under topics including Anti-asthmatic agents, Beta-adrenergic agonists and Chemical pages without DrugBank identifier.
Its subject is documented across 8 Wikipedia language editions.
Research
91 papers- Reproterol: beta-2-agonist, theophylline, or both?Respiration; international review of thoracic diseases · 1999
- Cromoglycate, reproterol, or both--what's best for exercise-induced asthma?Sleep & breathing = Schlaf & Atmung · 2012
- Inhibition by reproterol of cAMP PDE in intact mastocytoma P-815 cells.Pulmonary pharmacology & therapeutics · 2004
- Excretion study of the beta2-agonist reproterol in human urine.Journal of chromatography. B, Biomedical sciences and applications · 1999
- Reproterol--A monomolecular combination of orciprenaline and theophylline: novel aspects of its mode of action in asthma.Respiration; international review of thoracic diseases · 1999
via PubMed
Wikidata facts
- Mass
- 389.17
Show 3 more facts
- chemical formula
- C₁₈H₂₃N₅O₅
- canonical SMILES
- CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CCCNCC(C3=CC(=CC(=C3)O)O)O
- Commons category
- Reproterol
via Wikidata · CC0
~2 min read
Encyclopedic overview
2 sectionsContents
- Stereochemistry
- References
{{Infobox drug | Verifiedfields = changed | verifiedrevid = 448131419 | IUPAC_name = (RS)-7-(3-{[2-(3,5-dihydroxyphenyl)-2-hydroxyethyl]amino}propyl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione | image = (RS)-Reproterol Structural Formula V1.svg | image_class = skin-invert-image | width = 250
| tradename = | Drugs.com = | pregnancy_AU = | pregnancy_US = | pregnancy_category = | legal_AU = | legal_CA = | legal_UK = | legal_US = | legal_DE = Rx only | legal_status = | routes_of_administration = Inhalation (MDI), IV
Excerpted from Wikipedia’s “reproterol” article, available under the CC BY-SA 4.0 licence.